Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.
Blood Adv
; 8(15): 3875-3879, 2024 Aug 13.
Article
in En
| MEDLINE
| ID: mdl-38815228
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
ADP-ribosyl Cyclase 1
/
Antibodies, Monoclonal, Humanized
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Blood Adv
Year:
2024
Document type:
Article
Affiliation country:
España